Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.52 |
| ▸ | GMNN | O75496 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | THPO | P40225 | 1/20 | 0.52 |
| ▸ | MTOR | P42345 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CETP | P11597 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | UBE2N | P61088 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12731069 | 1.00 | LMNA (0.52) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL177886 | 1.00 | LMNA (0.52) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL16653364 | 0.92 | CYP2D6 (0.61) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL11159 | 0.92 | CYP2D6 (0.61) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL5549292 | 0.92 | CYP2D6 (0.61) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL12198626 | 0.92 | CYP2D6 (0.61) | LMNACYP2D6SPHK1GMNNPOLB | |
| Bicarbonate SCHEMBL29012522 | 0.91 | CYP2D6 (0.45) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL25243382 | 0.90 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL1964037 | 0.90 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL10571108 | 0.90 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250275536-A1 | Antimicrobial Composition | KAMER, Patrick (CH) | 2025-09-04 | — | — | US | claimed |
| WO-2023213846-A1 | ANTIMICROBIAL COMPOSITION | KAMER PATRICK (CH) | 2023-11-09 | — | — | WO | claimed |
| CN-116751553-A | Double-component polyurethane sealant and application thereof in unmanned aerial vehicle field | 东莞市博翔电子材料有限公司 | 2023-09-15 | — | — | CN | claimed |
| US-20060068390-A1 | Dna amplification and sequencing in collapsible emulsions | NUCLEICS PTY LTD. (AU) | 2006-03-30 | — | — | US | claimed |
| EP-1069131-B1 | Methods for separating particulate substrates from solution while minimizing particle loss | QIAGEN GMBH (DE) | 2006-03-15 | — | — | EP | claimed |
| US-20040171077-A1 | Methods for separating particulate substrates from solution while minimizing particle loss | LUBENOW HELGE (DE) | 2004-09-02 | — | — | US | claimed |
| US-6723510-B2 | ISOLATION OF MOLECULES OF INTEREST USING AFFINITY PARTICLES WHERE AT LEAST ONE STEP IN THE ISOLATION IS DONE IN THE PRESENCE OF A DETERGENT WHICH REDUCES LOSS OF PARTICLES AND ENHANCES YIELD OF THE MOLECULE OF INTEREST | QIAGEN GMBH (DE) | 2004-04-20 | — | — | US | claimed |
| WO-2003106678-A1 | DNA AMPLIFICATION AND SEQUENCING IN COLLAPSIBLE EMULSIONS | NUCLEICS PTY LTD (AU) | 2003-12-24 | — | — | WO | claimed |
| US-20010014466-A1 | Methods for separating particulate substrates from solution while minimizing particle loss | LUBENOW HELGE (DE) | 2001-08-16 | — | — | US | claimed |
| EP-1069131-A1 | Methods for separating particulate substrates from solution while minimizing particle loss | QIAGEN GmbH (DE) | 2001-01-17 | — | — | EP | claimed |
| EP-4705420-A1 | ELECTRIC VEHICLE FLUIDS | Chevron Oronite Company LLC (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| US-20250275536-A1 | Antimicrobial Composition | KAMER, Patrick (CH) | 2025-09-04 | — | — | US | disclosed |
| WO-2023213310-A9 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| EP-3926045-B1 | MUTANT PROTEINS AND METHODS FOR SELECTING THEM | NXERA PHARMA UK LTD (GB) | 2025-01-01 | — | — | EP | disclosed |
| EP-0242380-A1 | A PROCESS FOR PREPARING IMMUNOGENIC COMPLEX. | MOREIN BROR | 1987-10-28 | — | — | EP | disclosed |
| WO-1987002250-A1 | A PROCESS FOR PREPARING IMMUNOGENIC COMPLEX | MOREIN BROR | 1987-04-23 | — | — | WO | disclosed |
| EP-0180564-A2 | Immunogenic complex, a method for producing the same, and the use thereof as an immune stimulant, vaccines and reagents | Morein, Bror (SE) | 1986-05-07 | — | — | EP | disclosed |
| US-4578269-A | Immunogenic protein or peptide complex, method or producing said complex and the use thereof as an immune stimulant and as a vaccine | MOREIN BROR (SE) | 1986-03-25 | — | — | US | disclosed |
| EP-0109942-A2 | Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine | Morein, Bror (SE) | 1984-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250275536-A1 | Antimicrobial Composition | CUTA, POLR1C, PIK3C3 | LMNA 2754/4885CYP2D6 2614/4885SPHK1 2428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.